Mark Avagliano - Net Worth and Insider Trading
Mark Avagliano Net Worth
The estimated net worth of Mark Avagliano is at least $2 Million dollars as of 2024-11-05. Mark Avagliano is the Chief Business Officer of G1 Therapeutics Inc and owns about 242,045 shares of G1 Therapeutics Inc (GTHX) stock worth over $2 Million. Details can be seen in Mark Avagliano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Avagliano has not made any transactions after 2024-07-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Avagliano
Mark Avagliano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Avagliano owns 1 companies in total, including G1 Therapeutics Inc (GTHX) .
Click here to see the complete history of Mark Avagliano’s form 4 insider trades.
Insider Ownership Summary of Mark Avagliano
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2024-07-05 | Chief Business Officer |
Mark Avagliano Latest Holdings Summary
Mark Avagliano currently owns a total of 1 stock. Mark Avagliano owns 242,045 shares of G1 Therapeutics Inc (GTHX) as of July 5, 2024, with a value of $2 Million.
Latest Holdings of Mark Avagliano
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2024-07-05 | 242,045 | 7.15 | 1,730,622 |
Holding Weightings of Mark Avagliano
Mark Avagliano Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Avagliano has made a total of 4 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in G1 Therapeutics Inc is the sale of 2,638 shares on July 5, 2024, which brought Mark Avagliano around $6,621.
Insider Trading History of Mark Avagliano
- 1
Mark Avagliano Trading Performance
Mark Avagliano Ownership Network
Ownership Network List of Mark Avagliano
Ownership Network Relation of Mark Avagliano
Mark Avagliano Owned Company Details
What does G1 Therapeutics Inc do?
Who are the key executives at G1 Therapeutics Inc?
Mark Avagliano is the Chief Business Officer of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Commercial Officer Andrew Perry , and Chief Operating Officer Terry L Murdock .
G1 Therapeutics Inc (GTHX) Insider Trades Summary
Over the past 18 months, Mark Avagliano made 3 insider transaction in G1 Therapeutics Inc (GTHX) with a net sale of 14,870. Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 78,166 shares made by Rajesh Malik , a net sale of 92,308 shares made by Bailey John E. (jack) Jr. , and a net sale of 15,968 shares made by John V. Umstead .
In summary, during the past 3 months, insiders sold 0 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 295,121 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 295,121 shares.
G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.
G1 Therapeutics Inc Insider Transactions
Mark Avagliano Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Avagliano. You might contact Mark Avagliano via mailing address: 79 T.w. Alexander Drive, 4501 Research Commons, Suite 100, Research Triangle Park Nc 27709.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
